Given that the absence of mTOR activity is characteristic of quiescent cells, and inhibition of mTOR kinase can alter the cellular proteome by 80% in cancer cells [16], translational reprogramming can be that one non-genetic mechanism determining the emergence of a latent phenotype in cancer cells and causing stem cell traits in dormant tumor cells. Here, MTOR is linked to cancer.